- Biomaterials
- Nanotechnology
- Drug Delivery
- +۷ مورد دیگر
Dr. Hu Yang is the Linda and Bipin Doshi Chair and Professor of Chemical and Biochemical Engineering at Missouri University of Science and Technology , serving as Department Chair and Director of the Center for Biomedical Research (CBR). He previously held the Qimonda Endowed Chair at Virginia Commonwealth University (VCU). His research focuses on nanotechnology-driven biomedical solutions, including drug delivery systems, dendrimer engineering, and treatments for cancer, glaucoma, and atherosclerosis. He has secured over $10M in research funding, including NSF and Coulter Awards, and holds five patents. Education: B.S. in Polymer Science from Sichuan University (1998), Ph.D. in Chemical Engineering from the University of Akron (2004), and postdoctoral training in pharmaceutical sciences at the University of Wisconsin-Madison. Research Interests: Biomaterials, nanotechnology, targeted drug delivery, gene therapy, ocular disease treatments, and pharmaceutical engineering. Key projects include ROS-responsive nanoassemblies for atherosclerosis, cancer cell membrane-derived vaccines, and dendrimer-based hydrogels for retinoblastoma treatment. Publications: Over 120 peer-reviewed articles, with recent work in Advanced Science , Biomacromolecules , and Journal of Agricultural and Food Chemistry . Themes include nanoparticle analysis in plant tissues, glaucoma therapy, and neuroinflammation studies. Awards: NSF CAREER Award (2010), Coulter Young Investigator Award (2009), and recognition as a top 2% cited scientist (Stanford, 2024). Grants & Leadership: Primary investigator on $5.5M NIH/NSF grants. Editorial roles include Materials Express and Smart Materials in Medicine . Lab: Drug and Gene Delivery Laboratory at Missouri S&T. Additional Roles: Member of the Massey Cancer Center (VCU), grant reviewer for NIH/NSF, and advocate for diversity in STEM education.











